Kluiver, Thomas A. https://orcid.org/0000-0003-2224-480X
Lu, Yuyan https://orcid.org/0009-0000-6374-1357
Schubert, Stephanie A. https://orcid.org/0000-0002-8655-1350
Kraaier, Lianne J.
Ringnalda, Femke https://orcid.org/0000-0002-0684-4613
Lijnzaad, Philip https://orcid.org/0000-0002-7535-583X
DeMartino, Jeff https://orcid.org/0000-0001-7366-4789
Megchelenbrink, Wouter L. https://orcid.org/0000-0002-2895-3511
Amo-Addae, Vicky
Eising, Selma
de Faria, Flavia W.
Münter, Daniel https://orcid.org/0000-0001-8823-0238
van de Wetering, Marc https://orcid.org/0000-0002-8195-9939
Kerl, Kornelius https://orcid.org/0000-0002-5676-8102
Duiker, Evelien https://orcid.org/0000-0002-9450-5282
van den Heuvel, Marius C.
de Meijer, Vincent E. https://orcid.org/0000-0002-7900-5917
de Kleine, Ruben H. https://orcid.org/0000-0003-3975-3184
Molenaar, Jan J.
Margaritis, Thanasis https://orcid.org/0000-0003-4040-2015
Stunnenberg, Hendrik G. https://orcid.org/0000-0002-0066-1576
de Krijger, Ronald R.
Zsiros, József
Clevers, Hans https://orcid.org/0000-0002-3077-5582
Peng, Weng Chuan https://orcid.org/0000-0001-5467-5458
Funding for this research was provided by:
Stichting Kinderen Kankervrij (425)
Article History
Received: 25 October 2023
Accepted: 20 September 2024
First Online: 20 November 2024
Competing interests
: H.C. is currently head of pharma Research Early Development (pRED) at Roche and is an inventor on several patents related to organoid technology. His full disclosure is given at . The remaining authors declare no competing interests.